Stablecoin Development Corporation Revenue per Employee (SDEV), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Stablecoin Development Corporation  (SDEV)
 

Stablecoin Development's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Stablecoin Development's Revenue per employee grew on a trailing twelve month basis to $ 855,250, above the company average.
Within the Healthcare sector Stablecoin Development Corporation achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Stablecoin Development has 4 employees.


What is Sales per Employee Ratio?







SDEV Revenue per Employee (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Revenue Change - -78.25 % -78.66 % - -
Sales per Employee (TTM) $ 855,250 239,500 632,500 1,112,500 1,712,500
SDEV's Total Ranking # # # # #
Seq. Revenue Change 463.62 % -16.12 % - - -


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 4,557,500 $ 2,201,603 $ -513,750
(Dec 31 2017)   (Sep 30 2014)



Financial Statements
Stablecoin Development's Revenue MRQ $ 2 Millions Visit SDEV's Income Statement
Stablecoin Development's Revenues TTM $ 3 Millions Visit SDEV's aggregate revenue growth
What are SDEV's Sales? Visit SDEV's Sales by Segment




Other Ratios
Stablecoin Development's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SDEV's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SDEV's Competitors
Revenue per Employee for SDEV's Suppliers
Revenue per Employee for SDEV's Customers

You may also want to know
SDEV's Sales Growth Rates SDEV's Pe Price to earnings ratio SDEV's Receivables Turnover Ratio SDEV's Stock Quote
SDEV's Net Income Growth Rates SDEV's Ps Price to Sales ratio SDEV's Sales per Employee SDEV's Asset Turnover Ratio
SDEV's Net Margin SDEV's Pb Price to Book ratio SDEV's Financial Strength Ratios SDEV's Dividend Payout Ratio
Date modified: 2026-08-30T14:38:06+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Apellis Pharmaceuticals Inc   1,495,642.76 $ 1,105.280  Million 739 
Bristol myers Squibb Company  1,491,753.85 $ 48,482.000  Million 32,500 
Fennec Pharmaceuticals Inc   1,457,114.29 $ 50.999  Million 35 
Tarsus Pharmaceuticals Inc   1,446,159.46 $ 535.079  Million 370 
Eli Lilly And Company  1,444,990.00 $ 72,249.500  Million 50,000 
Esperion Therapeutics Inc   1,422,598.64 $ 418.244  Million 294 
Krystal Biotech Inc   1,414,589.83 $ 417.304  Million 295 
Acadia Pharmaceuticals Inc   1,372,493.73 $ 1,095.250  Million 798 
Liquidia Corporation  1,333,634.26 $ 288.065  Million 216 
Biogen Inc   1,324,986.67 $ 9,937.400  Million 7,500 
Lantheus Holdings Inc   1,295,200.34 $ 1,545.174  Million 1,193 
Indivior Pharmaceuticals Inc   1,292,000.00 $ 1,292.000  Million 1,000 
Puma Biotechnology Inc   1,269,150.84 $ 227.178  Million 179 
Madrigal Pharmaceuticals Inc   1,237,693.99 $ 1,132.490  Million 915 
Theravance Biopharma inc   1,219,722.22 $ 109.775  Million 90 
Akebia Therapeutics Inc   1,197,958.76 $ 232.404  Million 194 
Supernus Pharmaceuticals inc   1,191,461.66 $ 776.833  Million 652 
Arcutis Biotherapeutics Inc   1,174,079.10 $ 415.624  Million 354 
Heron Therapeutics Inc   1,173,312.50 $ 150.184  Million 128 
Cue Biopharma Inc   1,128,655.17 $ 32.731  Million 29 
Journey Medical Corp  1,115,172.41 $ 64.680  Million 58 
Abbvie Inc   1,102,087.72 $ 62,819.000  Million 57,000 
Travere Therapeutics Inc   1,078,863.18 $ 536.195  Million 497 
Corcept Therapeutics Inc  1,053,556.16 $ 769.096  Million 730 
Biomarin Pharmaceutical Inc  1,006,617.82 $ 3,242.316  Million 3,221 
Scilex Holding Company  995,941.18 $ 33.862  Million 34 
Coya Therapeutics Inc   992,377.00 $ 7.939  Million
Sanara Medtech Inc   989,563.23 $ 106.873  Million 108 
Assembly Biosciences Inc   973,931.51 $ 71.097  Million 73 
Hims and Hers Health Inc   970,301.39 $ 2,369.476  Million 2,442 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.